Concepedia

Jeffrey A. Meridew

JA

Statistics

Publications

15

Citations

902

H-Index

12

Active since

2016

Affiliations

Mayo Clinic(Current)

Boston University

Mayo Clinic in Florida

WinnMed

University of Michigan

Jeffrey A. Meridew is an author at Mayo Clinic specializing in fibrosis, life sciences, and molecular biology.

Publications per year

2016–2023

15

Publications

15

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis

Andrew J. Haak, Enis Kostallari, Delphine Sicard et al. · Science Translational Medicine · 2019 · 218 citations · Full text

, , +17

PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state

Nunzia Caporarello, Jeffrey A. Meridew, Dakota L. Jones et al. · Thorax · 2019 · 95 citations · Full text

, , +17

CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis

Giovanni Ligresti, Nunzia Caporarello, Jeffrey A. Meridew et al. · JCI Insight · 2019 · 91 citations · Full text

, , +14

Dysfunctional ERG signaling drives pulmonary vascular aging and persistent fibrosis

Nunzia Caporarello, Jisu Lee, Tho X. Pham et al. · Nature Communications · 2022 · 85 citations · Full text

, , +17

Vascular dysfunction in aged mice contributes to persistent lung fibrosis

Nunzia Caporarello, Jeffrey A. Meridew, Aja Aravamudhan et al. · Aging Cell · 2020 · 71 citations · Full text

, , +17

1–5 of 15